pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
Divalproex Sodium DR Viatris
Divalproex Sodium (divalproex sodium)
Absence Seizure
Mylan Pharmaceuticals Inc
0 catalysts
Marketed
Dobutamine Hydrochloride Pfizer
Dobutamine Hydrochloride (dobutamine hydrochloride)
Congestive Heart Failure (Heart Failure)
$PFEPFIZER INC
0 catalysts
Marketed
Dorlan
Flurbiprofen (flurbiprofen)
Osteoarthritis Pain
Teva Pharmaceuticals USA Inc
0 catalysts
← prev
page 88 of 271
next →
131
Pain89
Neurology1
Marketed
Doryx
Doryx MPC (doxycycline hyclate)
Actinomycosis
Mayne Pharma USA Inc
0 catalysts
Marketed
Doxorubicin Teva
Doxorubicin Hydrochloride (doxorubicin)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Teva Pharmaceuticals USA Inc
0 catalysts
Preclinical
Drug for Anal Fissure
Anal Fissure
Steel Therapeutics Inc
0 catalysts
Phase 1
Drug for Unspecified Dermatological Disorders
Unspecified Dermatological Disorders
Neutrophil collagenaseInterstitial collagenase
TBT Pharma Inc
0 catalysts
Preclinical
Drug to Inhibit MDM2 for Retinoblastoma
Retinoblastoma
Spectocular LLC
0 catalysts
Preclinical
Drugs for Oncology
Pancreatic Ductal Adenocarcinoma
SRI International
0 catalysts
Marketed
Duac
Benzoyl Peroxide + Clindamycin Phosphate Prasco ((benzoyl peroxide + clindamycin phosphate))
Acne Vulgaris
Prasco LLC
0 catalysts
Marketed
Duraclon
Duraclon (clonidine hydrochloride)
Cancer Pain
Mylan Pharmaceuticals Inc
0 catalysts
Phase 1
E-1018
Malaria
Eisai Co Ltd
0 catalysts
Preclinical
E-1V111
Spinal Muscular Atrophy (SMA)
Shift Pharmaceuticals
0 catalysts
Phase 1
E-2025
Alzheimer's Disease
Eisai Co Ltd
0 catalysts
Phase 1
E-2086
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
Eisai Co Ltd
0 catalysts
Phase 1
E-2511
Alzheimer's Disease
Eisai Co Ltd
0 catalysts
Phase 1
E-7766
Solid Tumor
Eisai Co Ltd
0 catalysts
Preclinical
EB-002
Anxiety Disorders
MycoMedica Life Sciences PBC
0 catalysts
Preclinical
EB-003
Hemolytic Uremic Syndrome
Eligo Bioscience SA
0 catalysts
Preclinical
EB-07
paridiprubart [INN]
Pulmonary Fibrosis
$EDSAEdesa Biotech, Inc.
0 catalysts
Phase 2
EB-103
B-Cell Non-Hodgkin Lymphoma
$ESLAEstrella Immunopharma, Inc.
0 catalysts
Preclinical
EB-104
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$ESLAEstrella Immunopharma, Inc.
0 catalysts
Phase 1
EB-105
Diabetic Macular Edema
Eluminex Biosciences Ltd
0 catalysts
EBANGA
EBANGA (ANSUVIMAB-ZYKL)
Ridgeback Biotherapeutics LLC
0 catalysts
Phase 1
EBC-129
Pancreatic Ductal Adenocarcinoma
Agency for Science, Technology and Research
0 catalysts
EBGLYSS
EBGLYSS (LEBRIKIZUMAB-LBKZ)
1 INDICATIONS AND USAGE EBGLYSS is indicated for the treatment of adults and…
Interleukin-13
$LLYELI LILLY & Co
0 catalysts
Phase 2
EBT-101
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Excision BioTherapeutics Inc
0 catalysts
Phase 2
ECC-0509
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Eccogene (Shanghai) Co Ltd
0 catalysts
Phase 2
ECC-4703
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Eccogene (Shanghai) Co Ltd
0 catalysts
Phase 3
ECUR-506
Ornithine-Transcarbamylase Deficiency
iECURE Inc
0 catalysts